217 related articles for article (PubMed ID: 2036375)
1. A type I collagen with substitution of a cysteine for glycine-748 in the alpha 1(I) chain copolymerizes with normal type I collagen and can generate fractallike structures.
Kadler KE; Torre-Blanco A; Adachi E; Vogel BE; Hojima Y; Prockop DJ
Biochemistry; 1991 May; 30(20):5081-8. PubMed ID: 2036375
[TBL] [Abstract][Full Text] [Related]
2. Copolymerization of normal type I collagen with three mutated type I collagens containing substitutions of cysteine at different glycine positions in the alpha 1 (I) chain.
Torre-Blanco A; Adachi E; Romanic AM; Prockop DJ
J Biol Chem; 1992 Mar; 267(7):4968-73. PubMed ID: 1537873
[TBL] [Abstract][Full Text] [Related]
3. Type I procollagens containing substitutions of aspartate, arginine, and cysteine for glycine in the pro alpha 1 (I) chain are cleaved slowly by N-proteinase, but only the cysteine substitution introduces a kink in the molecule.
Lightfoot SJ; Holmes DF; Brass A; Grant ME; Byers PH; Kadler KE
J Biol Chem; 1992 Dec; 267(35):25521-8. PubMed ID: 1460046
[TBL] [Abstract][Full Text] [Related]
4. Self-assembly of collagen I from a proband homozygous for a mutation that substituted serine for glycine at position 661 in the alpha 2(I) chain. Possible relationship between the effects of mutations on critical concentration and the severity of the phenotype.
Romanic AM; Spotila LD; Adachi E; Engel J; Hojima Y; Prockop DJ
J Biol Chem; 1994 Apr; 269(15):11614-9. PubMed ID: 8157695
[TBL] [Abstract][Full Text] [Related]
5. The molecular defect in an autosomal dominant form of osteogenesis imperfecta. Synthesis of type I procollagen containing cysteine in the triple-helical domain of pro-alpha 1(I) chains.
de Vries WN; de Wet WJ
J Biol Chem; 1986 Jul; 261(19):9056-64. PubMed ID: 3722186
[TBL] [Abstract][Full Text] [Related]
6. Substitutions of aspartic acid for glycine-220 and of arginine for glycine-664 in the triple helix of the pro alpha 1(I) chain of type I procollagen produce lethal osteogenesis imperfecta and disrupt the ability of collagen fibrils to incorporate crystalline hydroxyapatite.
Culbert AA; Lowe MP; Atkinson M; Byers PH; Wallis GA; Kadler KE
Biochem J; 1995 Nov; 311 ( Pt 3)(Pt 3):815-20. PubMed ID: 7487936
[TBL] [Abstract][Full Text] [Related]
7. Substitution of cysteine for glycine-alpha 1-691 in the pro alpha 1(I) chain of type I procollagen in a proband with lethal osteogenesis imperfecta destabilizes the triple helix at a site C-terminal to the substitution.
Steinmann B; Westerhausen A; Constantinou CD; Superti-Furga A; Prockop DJ
Biochem J; 1991 Nov; 279 ( Pt 3)(Pt 3):747-52. PubMed ID: 1953667
[TBL] [Abstract][Full Text] [Related]
8. A lethal variant of osteogenesis imperfecta has a single base mutation that substitutes cysteine for glycine 904 of the alpha 1(I) chain of type I procollagen. The asymptomatic mother has an unidentified mutation producing an overmodified and unstable type I procollagen.
Constantinou CD; Nielsen KB; Prockop DJ
J Clin Invest; 1989 Feb; 83(2):574-84. PubMed ID: 2913053
[TBL] [Abstract][Full Text] [Related]
9. A point mutation in a type I procollagen gene converts glycine 748 of the alpha 1 chain to cysteine and destabilizes the triple helix in a lethal variant of osteogenesis imperfecta.
Vogel BE; Minor RR; Freund M; Prockop DJ
J Biol Chem; 1987 Oct; 262(30):14737-44. PubMed ID: 3667599
[TBL] [Abstract][Full Text] [Related]
10. Substitution of serine for alpha 1(I)-glycine 844 in a severe variant of osteogenesis imperfecta minimally destabilizes the triple helix of type I procollagen. The effects of glycine substitutions on thermal stability are either position of amino acid specific.
Pack M; Constantinou CD; Kalia K; Nielsen KB; Prockop DJ
J Biol Chem; 1989 Nov; 264(33):19694-9. PubMed ID: 2511192
[TBL] [Abstract][Full Text] [Related]
11. Substitution of serine for glycine 883 in the triple helix of the pro alpha 1 (I) chain of type I procollagen produces osteogenesis imperfecta type IV and introduces a structural change in the triple helix that does not alter cleavage of the molecule by procollagen N-proteinase.
Lightfoot SJ; Atkinson MS; Murphy G; Byers PH; Kadler KE
J Biol Chem; 1994 Dec; 269(48):30352-7. PubMed ID: 7982948
[TBL] [Abstract][Full Text] [Related]
12. Delayed triple helix formation of mutant collagen from patients with osteogenesis imperfecta.
Raghunath M; Bruckner P; Steinmann B
J Mol Biol; 1994 Feb; 236(3):940-9. PubMed ID: 8114103
[TBL] [Abstract][Full Text] [Related]
13. Endoplasmic reticulum-mediated quality control of type I collagen production by cells from osteogenesis imperfecta patients with mutations in the pro alpha 1 (I) chain carboxyl-terminal propeptide which impair subunit assembly.
Lamandé SR; Chessler SD; Golub SB; Byers PH; Chan D; Cole WG; Sillence DO; Bateman JF
J Biol Chem; 1995 Apr; 270(15):8642-9. PubMed ID: 7721766
[TBL] [Abstract][Full Text] [Related]
14. Substitution of cysteine for glycine-946 in the alpha 1(I) chain of type I procollagen causes lethal osteogenesis imperfecta.
Kurosaka D; Hattori S; Hori H; Yamaguchi N; Hasegawa T; Akimoto H; Nagai Y
J Biochem; 1994 May; 115(5):853-7. PubMed ID: 7961597
[TBL] [Abstract][Full Text] [Related]
15. Mutations that substitute serine for glycine alpha 1-598 and glycine alpha 1-631 in type I procollagen. The effects on thermal unfolding of the triple helix are position-specific and demonstrate that the protein unfolds through a series of cooperative blocks.
Westerhausen A; Kishi J; Prockop DJ
J Biol Chem; 1990 Aug; 265(23):13995-4000. PubMed ID: 2116413
[TBL] [Abstract][Full Text] [Related]
16. A cysteine for glycine substitution at position 175 in an alpha 1 (I) chain of type I collagen produces a clinically heterogeneous form of osteogenesis imperfecta.
Wirtz MK; Rao VH; Glanville RW; Labhard ME; Pretorius PJ; de Vries WN; de Wet WJ; Hollister DW
Connect Tissue Res; 1993; 29(1):1-11. PubMed ID: 8339541
[TBL] [Abstract][Full Text] [Related]
17. Recurrence of lethal osteogenesis imperfecta due to parental mosaicism for a mutation in the COL1A2 gene of type I collagen. The mosaic parent exhibits phenotypic features of a mild form of the disease.
Edwards MJ; Wenstrup RJ; Byers PH; Cohn DH
Hum Mutat; 1992; 1(1):47-54. PubMed ID: 1301191
[TBL] [Abstract][Full Text] [Related]
18. A de novo G to T transversion in a pro-alpha 1 (I) collagen gene for a moderate case of osteogenesis imperfecta. Substitution of cysteine for glycine 178 in the triple helical domain.
Valli M; Mottes M; Tenni R; Sangalli A; Gomez Lira M; Rossi A; Antoniazzi F; Cetta G; Pignatti PF
J Biol Chem; 1991 Jan; 266(3):1872-8. PubMed ID: 1988452
[TBL] [Abstract][Full Text] [Related]
19. Two cysteine substitutions in procollagen I: a glycine replacement near the N-terminus of alpha 1(I) chain causes lethal osteogenesis imperfecta and a glycine replacement in the alpha 2(I) chain markedly destabilizes the triple helix.
Fertala A; Westerhausen A; Morris G; Rooney JE; Prockop DJ
Biochem J; 1993 Jan; 289 ( Pt 1)(Pt 1):195-9. PubMed ID: 8424758
[TBL] [Abstract][Full Text] [Related]
20. Mutations that alter the primary structure of type I procollagen have long-range effects on its cleavage by procollagen N-proteinase.
Dombrowski KE; Vogel BE; Prockop DJ
Biochemistry; 1989 Aug; 28(17):7107-12. PubMed ID: 2684272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
